BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cystic Fibrosis Research and Translation Center (CFRTC) - ECPv4.9.12//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cystic Fibrosis Research and Translation Center (CFRTC)
X-ORIGINAL-URL:https://depts.washington.edu/cfrtc
X-WR-CALDESC:Events for Cystic Fibrosis Research and Translation Center (CFRTC)
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200528T160000
DTEND;TZID=America/Vancouver:20200528T170000
DTSTAMP:20241204T052647
CREATED:20191126T184350Z
LAST-MODIFIED:20200528T011541Z
UID:2119-1590681600-1590685200@depts.washington.edu
SUMMARY:Larry Kessler\, PhD and Ryan Hansen\, PhD
DESCRIPTION:Professor\, Health Services\, \nAssistant Professor\, Pharmacy\,\nUniversity of Washington \nTITLE: “Cost-Effectiveness Analysis (CEA) in Studies of Treatments for Cystic Fibrosis” \nWith increasing attention on obtaining value for health in the US health care system\, a commonly used tool to evaluate interventions is cost-effectiveness analysis (CEA). Sometimes those findings can create controversy among stakeholders\, including patients\, clinicians\, researchers\, and health care systems. For example\, on April 27\, 2020\, the Institute for Clinical and Economic Review (ICER) published a report titled Modulator Treatments for Cystic Fibrosis: Effectiveness and Value. They found a very high cost-effectiveness estimate for the new triple therapy Trikafta. ICER goes on to say\, “analyses suggest that the price set by the manufacturer would need to be deeply discounted to align fairly with these benefits and ensure that they are not outweighed by the negative health effects for others resulting from increasing insurance costs.” Why do we perform these analyses? What goes into a cost-effectiveness analysis? What decisions influence such analyses? In this seminar\, Ryan Hansen and Larry Kessler will provide a brief introduction to CEA\, briefly discuss methods and basic findings of the recent ICER report and use a local example of an ongoing CEA we are doing of the eICE Home Spirometry trial. \nZOOM LINK: https://washington.zoom.us/j/92110910112?pwd=b0ZyQkcwd1JqUHR4ZWV0VU5GL2hFdz09 \nDownload flyer here \n
URL:https://depts.washington.edu/cfrtc/event/larry-kessler-phd-and-ryan-hansen-phd/
LOCATION:ZOOM only meeting\, WA\, United States
END:VEVENT
END:VCALENDAR